Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Carmichael

Showing results (371-380 of 509) with videos related to

Pageof 51
Sort By:
British Journal of Cancer|January 7, 2012
Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumoursE Dean, M R Middleton, T Pwint, et al.
British Journal of Cancer|April 1, 1993
The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivoP A Philip, L Kaklamanis, J Carmichael, et al.
British Journal of Cancer|January 1, 1996
Phase II study of gemcitabine in patients with advanced pancreatic cancerJ Carmichael, U Fink, R C Russell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Assessment of renal toxicity by urinary enzymes in patients receiving chemotherapy with 8-methyl-8-acetylenic-putrescineJ Carmichael, B M Cantwell, A L Harris, et al.
The Journal of Surgical Research|July 1, 1988
Prevention of postoperative pericardial adhesions with hydrophilic polymer solutionsD A Duncan, Y Yaacobi, E P Goldberg, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1982
A multicentre phase II trial of vindesine in malignant melanomaJ Carmichael, R J Atkinson, K C Calman, et al.
The American Surgeon|August 25, 2025
The Utility of Cervical Spine MRI in Non-Examinable or NEXUS-Positive Patients With Suspected Blunt Cervical Spine TraumaSteven A Medeiros, Dylan J Carmichael, Summre N Blakely, et al.
British Journal of Cancer|January 19, 2005
Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro studyA Mukherjee, A D Westwell, T D Bradshaw, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II study of liarozole in advanced non-small cell lung cancerK J O'Byrne, C Han, K Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
In vivo modulation of glutathione by buthionine sulfoximine: effect on marrow response to melphalanA Russo, Z Tochner, T Phillips, et al.
Pageof 51

Showing results (371-380 of 509) with videos related to

Sort By:
Pageof 51
British Journal of Cancer|January 7, 2012
Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumoursE Dean, M R Middleton, T Pwint, et al.
British Journal of Cancer|April 1, 1993
The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivoP A Philip, L Kaklamanis, J Carmichael, et al.
British Journal of Cancer|January 1, 1996
Phase II study of gemcitabine in patients with advanced pancreatic cancerJ Carmichael, U Fink, R C Russell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Assessment of renal toxicity by urinary enzymes in patients receiving chemotherapy with 8-methyl-8-acetylenic-putrescineJ Carmichael, B M Cantwell, A L Harris, et al.
The Journal of Surgical Research|July 1, 1988
Prevention of postoperative pericardial adhesions with hydrophilic polymer solutionsD A Duncan, Y Yaacobi, E P Goldberg, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1982
A multicentre phase II trial of vindesine in malignant melanomaJ Carmichael, R J Atkinson, K C Calman, et al.
The American Surgeon|August 25, 2025
The Utility of Cervical Spine MRI in Non-Examinable or NEXUS-Positive Patients With Suspected Blunt Cervical Spine TraumaSteven A Medeiros, Dylan J Carmichael, Summre N Blakely, et al.
British Journal of Cancer|January 19, 2005
Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro studyA Mukherjee, A D Westwell, T D Bradshaw, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II study of liarozole in advanced non-small cell lung cancerK J O'Byrne, C Han, K Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1986
In vivo modulation of glutathione by buthionine sulfoximine: effect on marrow response to melphalanA Russo, Z Tochner, T Phillips, et al.
Pageof 51